LPL Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Sell
12,500
-19,000
-60% -$497K ﹤0.01% 5454
2026
Q1
$885K Buy
31,500
+1,000
+3% +$26.6K ﹤0.01% 4287
2025
Q4
$759K Buy
30,500
+19,000
+165% +$479K ﹤0.01% 4348
2025
Q3
$293K Sell
11,500
-60,000
-84% -$1.48M ﹤0.01% 5065
2025
Q2
$1.73M Buy
71,500
+27,000
+61% +$630K ﹤0.01% 3262
2025
Q1
$1.13M Buy
44,500
+20,100
+82% +$526K ﹤0.01% 3450
2024
Q4
$647K Sell
24,400
-20,600
-46% -$559K ﹤0.01% 3868
2024
Q3
$1.3M Sell
45,000
-2,200
-5% -$64.2K ﹤0.01% 3139
2024
Q2
$1.32M Buy
47,200
+46,830
+12,657% +$1.29M ﹤0.01% 2986
2024
Q1
$1.03M Buy
+370
New +$10.3K ﹤0.01% 3158

Other funds holding PFE

LPL Financial's PFE Position: Q2 2026 in Review

LPL Financial increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $13.8M and bringing the position to 13,919,821 shares worth $335M. The position accounts for 0.08% of the portfolio, ranked #261.

LPL Financial first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $376M in Q1 2026. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LPL Financial held 13,919,821 shares of Pfizer worth $335M as of Q2 2026.
  • LPL Financial bought 526,160 Pfizer shares in Q2 2026, an estimated $13.8M.
  • Pfizer made up 0.08% of LPL Financial's portfolio in Q2 2026, its #261 holding.
  • LPL Financial first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Pfizer position peaked at $376M in Q1 2026.
  • 2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.